SARS-CoV-2 Severe Acute Respiratory Syndrome Coronavirus 2-related pneumonia referred to as COVID-19 Coronavirus Disease 19 is a public health emergency as it carries high morbidity mortality and has no approved specific pharmacological treatments. In this case series we aimed to report preliminary data obtained with anti-complement C5 therapy with eculizumab in COVID-19 patients admitted to intensive care unit ICU of ASL Napoli 2 Nord. Eculizumab treatment in patients with COVID-19: preliminary results from real life ASL Napoli 2 Nord experience.